Office of Primary Care and Area Health Education Centers (AHEC) Program

Eric Bergeron, a patient who has received the treatment (left), with CAR T program leader James Gerson, M.D., assistant professor of medicine

(JUNE 18, 2024) James Gerson, M.D., assistant professor of medicine, spoke with WCAX-TV about a new treatment for blood cancer launched last year that appears to be saving lives.

The novel, highly effective form of cancer treatment is called CAR T-cell therapy, and the UVM Cancer Center (UVMCC) is the only health care institution in Vermont and northern New York where it is available. The CAR T program is led by Gerson, who came to UVM from the University of Pennsylvania, where CAR T-cell therapy was discovered and developed.

UVMCC officials say 12 patients have been treated and many of them are still free of cancer. Eric Bergeron, a patient who has received the treatment, joined Gerson in the WCAX interview.

Read the full story at the UVM Cancer Center webpage.